BIOGEN INC. - COMMON STOCK

Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease

30 7月 2024 07:30:00 条件 Nasdaq GlobeNewswire

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

26 7月 2024 07:20:38 条件 Nasdaq GlobeNewswire

Biogen Completes Acquisition of Human Immunology Biosciences

02 7月 2024 09:16:51 条件 Nasdaq GlobeNewswire

“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China

27 6月 2024 19:39:36 条件 Nasdaq GlobeNewswire

TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union

24 6月 2024 07:30:00 条件 Nasdaq GlobeNewswire

FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

09 6月 2024 19:37:43 条件 Nasdaq GlobeNewswire

Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel

03 6月 2024 07:30:00 条件 Nasdaq GlobeNewswire

Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS

30 5月 2024 16:51:04 条件 Nasdaq GlobeNewswire

Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences

22 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire

Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis

16 5月 2024 07:30:14 条件 Nasdaq GlobeNewswire

Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status

14 5月 2024 19:33:37 条件 Nasdaq GlobeNewswire

Biogen Reports Progress on Corporate Responsibility Priorities

02 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire

Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®

25 4月 2024 16:05:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

19 4月 2024 09:50:39 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

18 4月 2024 09:45:07 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

17 4月 2024 09:50:10 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

16 4月 2024 09:45:06 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

15 4月 2024 09:45:35 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

12 4月 2024 12:00:50 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

10 4月 2024 09:45:08 条件 NetDania Notify